NEW EMPRINT™ HP ABLATION GENERATOR
please join us for our educational symposium
Taking Microwave Ablation to the Next Level
Presenter: Dr. Driss Raissi, Associate Professor of Radiology, Medicine, and Surgery and Obstetrics & Gynecology Chief
Division of Vascular & Interventional Radiology, University of Kentucky
Tuesday, March 23
4:10–4:50 p.m. EST
Emprint™ HP ablation generator with Thermosphere™ Technology
The Emprint™ ablation system enables a minimally invasive procedure with few side effects,1 fast recovery time,2,3 high accuracy,4 and predictable margins.5
Take less healthy liver, help preserve their future.6,7
Successful management of nonresectable liver tumors is about more than what you remove — it’s about what you leave behind, too.
The Emprint™ ablation system enables a minimally invasive procedure that provides immediate, repeatable results4 and can help lower the chance of recurrence.8 This procedure can also be combined with additional therapies and help you give your patients a more comprehensive treatment.6
Indications for use
The Medtronic Emprint™ ablation platform with Thermosphere™ technology is intended for use in percutaneous, laparoscopic, and intraoperative coagulation (ablation) of soft tissue, including partial or complete ablation of non-resectable liver tumors.
The Medtronic Emprint™ ablation system is not intended for use in cardiac procedures.
Microwave ablation procedures are not recommended for patients with cardiac pacemakers or other implanted electronic devices. Potential risks have not been evaluated.
Microwave ablation procedures are not recommended for pregnant patients. Potential risks to the patient an/or fetus have not been established.
Do not defibrillate a patient with an antenna inserted. Completely remove the antenna from the patient before defibrillation.
Residual risks include:
Foreign body in patient, foreign body reaction, additional needle stick or puncture, delay of treatment, post ablation syndrome, pain, fever, malaise, nausea, vomiting, myalgia, inflammation, hemorrhage, hemoptysis, hematoma, infection, peritonitis, abscess, ascites, seroma, wound dehiscence, adhesions, ischemia, necrosis, urinary retention, emphysema, pleural effusion, pneumothorax, pulmonary or upper respiratory fistula, hemothorax, dyspnea, biliary stenosis, biliary obstruction, biloma, cholangitis, biliary cirrhosis, haemobilia, gastrointestinal fistula, liver dysfunction, hepatic insufficiency, hepatic infarction, jaundice, colonic perforation, renal fistula, embolism, death, atrial fibrillation, tachycardia, cardiomyopathy, arteriovenous fistula, and cancer seeding.
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006 Mar;243(3):321–328.
Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia. 2015;31(7):749–757.
Zhang M. Ma H, Zhang J, He L, Ye X, Li X. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta analysis. Onco Targets Ther. 2017;10:4829–4839.
De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.
Vogl TJ, Basten LM, Nour-Eldin A, et al. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. Int J Hyperthermia. 2018;34(4):492–500.
Ruers T, Van Coevorden F, Punt CJA, et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.
Drake TM, Harrison EM. Malignant liver tumours. Surgery. 2017;35(12):707–714.
Takahashi H et al. Local Recurrence After Microwave Thermosphere Ablation of Malignant Liver Tumors: Results of a Surgical Series. Surgery. 2018 Apr;163(4):709-713.